Besides the tumor cells, various host immune cells and stromal cells in the complex tumor microenvironment maintain the expression of PD-L1, particularly myeloid cells and tumor-associated macrophages, IFN-γ dependent or not [45, 46]. The gene discussed is IFNG; the disease is neoplasm.